Literature DB >> 17491498

Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs.

Simon Whalley1, Prasanthi Puvanachandra, Atman Desai, Hugh Kennedy.   

Abstract

This paper discusses the annual incidence of liver disease and resource costs in providing a hepatology service for all new outpatient referrals to a secondary care setting. In a retrospective study, we found that 200 patients (1 in 1,000 of the West Suffolk population) with a mean age of 52 years were referred per year. One-third of patients had cirrhosis (almost half due to alcohol). Annual incidence (per 100,000 population) were as follows: non-alcoholic fatty liver disease (29: of which 23.5 non-cirrhotic and 5.5 cirrhotic), hepatitis C (25), hepatitis B (3), alcohol-related cirrhosis (12.5), primary biliary cirrhosis (3.5), autoimmune hepatitis (3), primary sclerosing cholangitis (2), haemochromatosis (2), hepatocellular carcinoma (1.5) and oesophageal variceal haemorrhage (6.5). Using national indicative tariffs, the total annual hepatology budget was 130K pounds (58K pounds for resources and 72K pounds for clinic attendances). The greatest resource expenditure was on endoscopy (almost half for oesophageal varices) and radiological imaging (one-third of the total budget). These findings will help inform commissioners in hepatology service funding.

Entities:  

Mesh:

Year:  2007        PMID: 17491498      PMCID: PMC4951824          DOI: 10.7861/clinmedicine.7-2-119

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  35 in total

1.  Autoimmune Hepatitis in Hawai'i.

Authors:  Tanner I Kim; Jaclyn E Kagihara; Naoky C S Tsai; Marina M Roytman
Journal:  Hawaii J Med Public Health       Date:  2015-08

Review 2.  Carotenoids and non-alcoholic fatty liver disease.

Authors:  Bahiddin Yilmaz; Kazim Sahin; Hande Bilen; Ibrahim H Bahcecioglu; Birdal Bilir; Sara Ashraf; Karim J Halazun; Omer Kucuk
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

Review 3.  Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.

Authors:  Kareem Hassan; Varun Bhalla; Mohammed Ezz El Regal; H Hesham A-Kader
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

Authors:  Alita Mishra; Zobair M Younossi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

Review 5.  Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease.

Authors:  Christine C Hsu; Erik Ness; Kris V Kowdley
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

6.  Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD).

Authors:  Ajay Duseja; Naga Chalasani
Journal:  Hepatol Int       Date:  2013-11-02       Impact factor: 6.047

7.  Staging of portal hypertension and portosystemic shunts using dynamic nuclear medicine investigations.

Authors:  Mircea Dragoteanu; Ioan-A Balea; Liliana-A Dina; Cecilia-D Piglesan; Ioana Grigorescu; Stefan Tamas; Sabin-O Cotul
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

Review 8.  Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.

Authors:  Zobair M Younossi; Linda Henry
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

9.  Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans.

Authors:  Jason W Wen; Michael A Kohn; Robert Wong; Ma Somsouk; Mandana Khalili; Jacquelyn Maher; Michele M Tana
Journal:  Am J Gastroenterol       Date:  2018-01-30       Impact factor: 10.864

Review 10.  Auto immune hepatitis.

Authors:  Nicole Mf van Gerven; Ynto S de Boer; Chris Jj Mulder; Carin Mj van Nieuwkerk; Gerd Bouma
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.